Cross Site Scripting vulnerability in the web application
Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).
| Vendor | Product | Default status | Versions | ||||||
|---|---|---|---|---|---|---|---|---|---|
| HCL | HCL MyXalytics | unaffected |
|
No data.
| Vendor | Product | Versions |
|---|---|---|
| Hcltech | Dryice Myxalytics | — |
Vendor Solution
For customers using older version, mitigation path will include upgrade to version 6.7 which in turn will fix the vulnerability during upgrade process
| Source | ID | Title |
|---|---|---|
EUVD |
EUVD-2025-32319 | HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access. |
No CVSS v4.0
No CVSS v3.0
No CVSS v2
This CVE is not in the KEV list.
Exploit prediction score: < 1% (0.265% probability within 30 days)
| Type | Values Removed | Values Added |
|---|---|---|
| CPEs | cpe:2.3:a:hcltech:dryice_myxalytics:6.6:*:*:*:*:*:*:* |
| Type | Values Removed | Values Added |
|---|---|---|
| First Time appeared |
Hcltech
Hcltech dryice Myxalytics |
|
| Vendors & Products |
Hcltech
Hcltech dryice Myxalytics |
| Type | Values Removed | Values Added |
|---|---|---|
| Metrics |
ssvc
|
| Type | Values Removed | Values Added |
|---|---|---|
| Description | HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access. | |
| Title | Cross Site Scripting vulnerability in the web application | |
| Weaknesses | CWE-79 | |
| References |
| |
| Metrics |
cvssV3_1
|